| |
| |
|
| Insider
Information: |
Hall Steven Edward |
| Relationship: |
Director |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
13,594,831 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$67,872,000 |
|
|
| Total
Shares |
13,594,831 |
|
|
| Total
Value |
$67,872,000 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Dare Bioscience Inc |
DARE |
Director, 10% Owner |
2014-04-15 |
0 |
2014-04-15 |
2,356,227 |
Premium* |
|
|
Protagonist Therapeutics, Inc |
PTGX |
10% Owner |
2016-08-16 |
0 |
2016-08-16 |
2,099,482 |
Premium* |
|
|
Aileron Therapeutics Inc |
ALRN |
Former 10% owner |
2017-07-05 |
0 |
2017-07-05 |
1,094,987 |
Premium* |
|
|
Surface Oncology, Inc. |
SURF |
10% Owner |
2018-04-23 |
0 |
2018-04-23 |
3,447,817 |
Premium* |
|
|
Forma Therapeutics Holdings, Inc., |
FMTX |
Director |
|
0 |
2020-06-23 |
2,404,069 |
Premium* |
|
|
Kymera Therapeutics, Inc. |
KYMR |
Director |
2020-08-25 |
0 |
2020-08-25 |
2,192,249 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
11 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KYMR |
Kymera Therapeutics, Inc. |
Director |
– • – |
2020-08-25 |
4 |
A |
$0.00 |
$0 |
I/I |
2,192,249 |
2,192,249 |
0 |
- |
|
| FMTX |
Forma Therapeutics Holdin... |
Director |
– • – |
2020-06-23 |
4 |
A |
$0.00 |
$0 |
I/I |
2,106,828 |
2,404,069 |
0 |
- |
|
| FMTX |
Forma Therapeutics Holdin... |
Director |
– • – |
2020-06-18 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
297,241 |
|
- |
|
| SURF |
Surface Oncology, Inc. |
10% Owner |
– – • |
2018-04-23 |
4 |
B |
$15.00 |
$3,990,000 |
I/I |
266,000 |
3,447,817 |
1.5 |
- |
|
| SURF |
Surface Oncology, Inc. |
10% Owner |
– – • |
2018-04-23 |
4 |
A |
$0.00 |
$0 |
I/I |
3,181,817 |
3,181,817 |
0 |
- |
|
| ALRN |
Aileron Therapeutics Inc |
Former 10% owner |
– – – |
2017-07-05 |
4 |
B |
$15.00 |
$3,750,000 |
I/I |
250,000 |
1,094,987 |
0.01 |
- |
|
| ALRN |
Aileron Therapeutics Inc |
Former 10% owner |
– – – |
2017-07-05 |
4 |
A |
$0.00 |
$0 |
I/I |
844,987 |
844,987 |
0 |
- |
|
| PTGX |
Protagonist Therapeutics,... |
10% Owner |
– – • |
2016-08-16 |
4 |
B |
$12.00 |
$6,999,996 |
I/I |
583,333 |
2,099,482 |
1.5 |
- |
|
| PTGX |
Protagonist Therapeutics,... |
10% Owner |
– – • |
2016-08-16 |
4 |
A |
$0.00 |
$0 |
I/I |
1,516,149 |
1,516,149 |
0 |
- |
|
| DARE |
Dare Bioscience Inc |
Director |
– • • |
2014-04-15 |
4 |
B |
$7.00 |
$5,134,115 |
I/I |
733,445 |
2,356,227 |
2.25 |
- |
|
| DARE |
Dare Bioscience Inc |
Director |
– • • |
2014-04-15 |
4 |
A |
$0.00 |
$0 |
I/I |
1,622,782 |
1,622,782 |
0 |
- |
|
11 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
